In most studies, GFAP was measured using ELISA techniques (expressed in ng/mL) (7) or did not include stroke patients beyond the hyperacute phase (8), thus limiting information in acute stroke of unknown or delayed onset. This evidence concerns the gene GFAP and Stroke.